Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis
Completed · Phase 3 · Has a placebo group
Conditions studied: Relapsing-Remitting Multiple Sclerosis
In brief
The primary study objective is to test the superiority of Daclizumab High Yield Process (DAC HYP) compared to interferon β 1a (IFN β-1a) in preventing multiple sclerosis (MS) relapse in participants with relapsing remitting multiple sclerosis. The secondary study objectives are to test the superiority of DAC HYP compared to IFN β-1a in slowing functional decline and disability progression and maintaining quality of life in this participant population.
Key facts
- Study ID
- NCT01064401
- Run by
- Biogen
- People needed
- 1841
- Starts
- 2010-05-01
- Expected to finish
- 2014-07-01
- Last updated by the study team
- 2016-07-11
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Phoenix, Arizona, United States
- Research Site — Tucson, Arizona, United States
- Research Site — Little Rock, Arkansas, United States
- Research Site — La Jolla, California, United States
- Research Site — Aurora, Colorado, United States
- Research Site — Naples, Florida, United States
- Research Site — Pompano Beach, Florida, United States
- Research Site — St. Petersburg, Florida, United States
- Research Site — Sunrise, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Evanston, Illinois, United States
- Research Site — Fort Wayne, Indiana, United States
- Research Site — Indianapolis, Indiana, United States
- Research Site — Des Moines, Iowa, United States
- Research Site — Kansas City, Kansas, United States
- Research Site — Lexington, Kentucky, United States
- Research Site — Baltimore, Maryland, United States
- Research Site — Springfield, Massachusetts, United States
- Research Site — Worchester, Massachusetts, United States
- Research Site — Clinton Township, Michigan, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Lebanon, New Hampshire, United States
- Research Site — New Brunswick, New Jersey, United States
- Research Site — Albuquerque, New Mexico, United States
- Research Site — Gilbert, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.